Amgen's Lumakras Gets FDA Nod for Expanded Use in Colorectal Cancer
The FDA approves Amgen's Lumakras in combination with Vectibix for treating previously treated adults with KRAS G12C-mutated metastatic colorectal cancer.
Le Lézard8 小时
Takeda's FRUZAQLAtm (fruquintinib) Receives Health Canada Market Authorization for ...
Takeda Canada Inc. ("Takeda") is pleased to announce that Health Canada has provided market authorization for FRUZAQLAtm (fruquintinib capsules), indicated for the treatment of adult patients with ...
Takeda's FRUZAQLA™ (fruquintinib) Receives Health Canada Market Authorization for ...
Takeda Canada Inc. ("Takeda") is pleased to announce that Health Canada has provided market authorization for FRUZAQLA™ ...